These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1630378)

  • 1. Antiretroviral agents in the nineties.
    Sutherland DC
    Med J Aust; 1992 Jul; 157(2):135-8. PubMed ID: 1630378
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early antiretroviral combination therapy--standard today and tomorrow].
    Dtsch Med Wochenschr; 1997 Mar; 122(11 Suppl):1-4. PubMed ID: 9102288
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiretroviral therapy in HIV infection].
    Jablonowski H
    Med Monatsschr Pharm; 1996 Jul; 19(7):196-205. PubMed ID: 8766922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-retroviral therapy and antiepileptics. Case report and discussion].
    Hug B; Kaeser YA; Haefeli WE; Battegay M
    Schweiz Med Wochenschr; 1998 Jul; 128(29-30):1138-44. PubMed ID: 9715501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antiretroviral therapy for the treatment of human immunodeficiency virus type-1 infection.
    Wilson CC; Hirsch MS
    Proc Assoc Am Physicians; 1995 Apr; 107(1):19-27. PubMed ID: 8630741
    [No Abstract]   [Full Text] [Related]  

  • 6. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of therapy of HIV infections. A long way to standardized procedure].
    Gürtler L
    Fortschr Med; 1993 Oct; 111(30):25-6. PubMed ID: 8258426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiretroviral treatments in human immunodeficiency virus infection].
    Dormont J; Aboulker JP
    Rev Prat; 1994 Jun; 44(12):1635-42. PubMed ID: 7939239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiretroviral treatment: are we entering or exiting the tunnel?].
    Gatell JM; Miró JM
    Med Clin (Barc); 1995 Apr; 104(16):622-5. PubMed ID: 7752715
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral chemotherapy against human immunodeficiency virus (hiv) infection: perspective for therapy of hepatitis B virus infection.
    Mitsuya H; Broder S
    Cancer Detect Prev; 1989; 14(2):299-308. PubMed ID: 2695248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral resistance and the selection of antiretroviral combinations.
    Larder BA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S28-33. PubMed ID: 8595505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy 1996.
    Beck JM
    J Ark Med Soc; 1996 Mar; 92(10):499-500. PubMed ID: 8867236
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral drug resistance.
    Japour AJ
    AIDS Clin Care; 1995 Aug; 7(8):63-5, 67. PubMed ID: 11362787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiretroviral therapy. Current status and perspectives].
    Lüthy R
    Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.
    Delaugerre C; Warszawski J; Chaix ML; Veber F; Macassa E; Buseyne F; Rouzioux C; Blanche S
    J Med Virol; 2007 Sep; 79(9):1261-9. PubMed ID: 17607781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV therapy advances. Early antiretroviral therapy.
    Cooper DA
    AIDS; 1994 Sep; 8 Suppl 3():S9-14. PubMed ID: 7840916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV.
    Crowe S; Cooper DA; Chambers DE
    Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amsterdam duration of antiretroviral medication (ADAM)--study: induction-suppression treatment in HIV-I infection, preliminary results].
    Reijers MH; Weverling GJ; Jurriaans S; Wit FW; van Leeuwen R; Bruisten SM; Frissen PH; Weigel HM; Mulder JW; ten Kate RW; de Wolf F; Schuitemaker H; Lange JM
    Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2230. PubMed ID: 10049092
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.
    Antinori A; Trotta MP; Nasta P; Bini T; Bonora S; Castagna A; Zaccarelli M; Quirino T; Landonio S; Merli S; Tozzi V; Di Perri G; Andreoni M; Perno CF; Carosi G
    Antivir Ther; 2006; 11(2):233-43. PubMed ID: 16640104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid screening of antiretroviral combinations.
    St Clair M; Pennington KN; Rooney J; Barry DW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S24-7. PubMed ID: 8595504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.